Fulgent Genetics, Inc. (FLGT)

USD 18.95

(-0.26%)

Total Liabilities Summary of Fulgent Genetics, Inc.

  • Fulgent Genetics, Inc.'s latest annual total liabilities in 2023 was 139.82 Million USD , up 20.35% from previous year.
  • Fulgent Genetics, Inc.'s latest quarterly total liabilities in 2024 Q1 was 103.23 Million USD , down -26.16% from previous quarter.
  • Fulgent Genetics, Inc. reported annual total liabilities of 116.17 Million USD in 2022, up 2.96% from previous year.
  • Fulgent Genetics, Inc. reported annual total liabilities of 112.84 Million USD in 2021, down -13.91% from previous year.
  • Fulgent Genetics, Inc. reported quarterly total liabilities of 103.39 Million USD for 2024 Q2, up 0.15% from previous quarter.
  • Fulgent Genetics, Inc. reported quarterly total liabilities of 91.25 Million USD for 2023 Q2, down -15.39% from previous quarter.

Annual Total Liabilities Chart of Fulgent Genetics, Inc. (2023 - 2001)

Historical Annual Total Liabilities of Fulgent Genetics, Inc. (2023 - 2001)

Year Total Liabilities Total Liabilities Growth
2023 139.82 Million USD 20.35%
2022 116.17 Million USD 2.96%
2021 112.84 Million USD -13.91%
2020 131.07 Million USD 2092.24%
2019 5.97 Million USD 117.81%
2018 2.74 Million USD -6.15%
2017 2.92 Million USD -17.86%
2016 3.56 Million USD 419.1%
2015 686 Thousand USD 57.34%
2014 436 Thousand USD 0.0%
2001 - USD 0.0%

Peer Total Liabilities Comparison of Fulgent Genetics, Inc.

Name Total Liabilities Total Liabilities Difference
Aspira Women's Health Inc. 8.62 Million USD -1520.76%
bioAffinity Technologies, Inc. 3.36 Million USD -4053.614%
Intelligent Bio Solutions Inc. 5.59 Million USD -2398.77%
Standard BioTools Inc. 159.86 Million USD 12.537%
Inotiv, Inc. 588.04 Million USD 76.222%
Prenetics Global Limited 44.01 Million USD -217.684%
Neuronetics, Inc. 81.64 Million USD -71.266%
Star Equity Holdings, Inc. 21.67 Million USD -545.089%
Castle Biosciences, Inc. 86.54 Million USD -61.567%
Psychemedics Corporation 6.59 Million USD -2019.172%
RadNet, Inc. 2.07 Billion USD 93.256%
Exact Sciences Corporation 3.32 Billion USD 95.796%
IDEXX Laboratories, Inc. 1.77 Billion USD 92.124%
iSpecimen Inc. 6.07 Million USD -2200.454%
OpGen, Inc. 13.44 Million USD -940.051%
Exagen Inc. 34.25 Million USD -308.242%
Bionano Genomics, Inc. 118.24 Million USD -18.247%
CareDx, Inc 223.28 Million USD 37.38%
Check-Cap Ltd. 1.33 Million USD -10413.008%
Twist Bioscience Corporation 152.97 Million USD 8.595%
Guardant Health, Inc. 1.62 Billion USD 91.41%
Biodesix, Inc. 94.51 Million USD -47.936%
BioNexus Gene Lab Corp. 1.74 Million USD -7926.851%
Precipio, Inc. 3.67 Million USD -3707.816%
Natera, Inc. 691.79 Million USD 79.788%
Sera Prognostics, Inc. 25.28 Million USD -453.032%
23andMe Holding Co. 206.64 Million USD 32.337%
OPKO Health, Inc. 622.47 Million USD 77.538%
Personalis, Inc. 95.65 Million USD -46.17%
Aclaris Therapeutics, Inc. 40.22 Million USD -247.594%
Applied DNA Sciences, Inc. 8.77 Million USD -1492.669%
T2 Biosystems, Inc. 62.83 Million USD -122.531%
Neogen Corporation 1.44 Billion USD 90.29%
Myriad Genetics, Inc. 312.9 Million USD 55.314%
ICON Public Limited Company 7.74 Billion USD 98.196%
NeoGenomics, Inc. 739.69 Million USD 81.097%
Star Equity Holdings, Inc. 21.67 Million USD -545.089%
MDxHealth SA 121.92 Million USD -14.68%
Prenetics Global Limited 44.01 Million USD -217.684%
Illumina, Inc. 4.36 Billion USD 96.797%
DarioHealth Corp. 38.24 Million USD -265.598%
ENDRA Life Sciences Inc. 1.09 Million USD -12667.393%
Medpace Holdings, Inc. 1.09 Billion USD 87.264%
Mainz Biomed B.V. 12.15 Million USD -1049.879%
Trinity Biotech plc 83.38 Million USD -67.686%
Sotera Health Company 2.68 Billion USD 94.796%
bioAffinity Technologies, Inc. 3.36 Million USD -4053.614%